US nod for malaria relapse treatment

By Linda A Johnson
Updated July 21 2018 - 12:56pm, first published 12:50pm
GlaxoSmithKline's Krintafel has been approved by US regulators to prevent malaria relapse.
GlaxoSmithKline's Krintafel has been approved by US regulators to prevent malaria relapse.

US regulators have approved a simpler, one-dose treatment to prevent relapses of malaria.

Get the latest St George news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.